Wilfried Ellmeier

Professor of Immunobiology
Head, Division of Immunobiology
Head, Institute of Immunology

Univ. Prof. Mag.Dr. Wilfried Ellmeier
Medical University of Vienna
Division of Immunobiology, Institute of Immunology
Center for Pathophysiology, Infectiology and Immunology
Lazarettgasse 19, 1090 Vienna, Austria
Phone: +43 1 40160 33293
E-mail: wilfried.ellmeier@meduniwien.ac.at

How to reach us

The Institute of Immunology is located in the Vienna Competence Center within walking distance (5 min) from:
• U6 Station Alserstraße
• Tram #43 or #44 (stop at "Skodagasse")
• Bus 13A (stop at "Skodagasse")
• Tram #5 or 33 (stop at "Spitalgasse")


++ 12/2020 - Alexandra Gülich receives a L'Oreal Austria Fellowship - FOR WOMEN IN SCIENCE <link>
++ 09/2020 - Wilfried Ellmeier has been reelected as FWF board (FWF Kuratorium) member <link>
++ 07/2020 - New review published in Advances in Immunology: Histone deacetylases as targets in autoimmune and autoinflammatory diseases <link>
++ 04/2020 - New publication in Frontiers Immunology: NCOR1 Orchestrates Transcriptional Landscapes and Effector Functions of CD4 + T Cells <link>
++ 02/2020 - New publication in JCI Insight: Histone Deacetylases 1 and 2 Restrain CD4+ Cytotoxic T Lymphocyte Differentiation <link>
++ 01/2020 - Wilfried Ellmeier starts his term as president of the Biomedical Alliance in Europe <link>
++ 12/2019 - New publication in Cell Reports: The Transcription Factor MAZR/PATZ1 Regulates the Development of FOXP3+ Regulatory T Cells <link>
++ 10/2019 - Wilfried Ellmeier is part of the organizing team that hosts the IUIS2025 congress in Vienna <link>
++ 06/2019 - Shinya Sakaguchi has been appointed as Associate Professor <link>
++ 05/2019 - New publication of the Sakaguchi laboratory: The zinc-finger transcription factor MAZR regulates iNKT cell subset differentiation <link>
++ 04/2019 - Wilfried Ellmeier has been appointed as member of the FWF Board (Kuratorium) <link>
++ 03/2019 - New publication in Frontiers in Immunology: Differential Requirement of Cd8 Enhancers E8I and E8VI in Cytotoxic Lineage T Cells and in Intestinal Intraepithelial Lymphocytes <link>
++ 12/2018 - Wilfried Ellmeier and Nicole Boucheron are part of a newly established Special Research Program (SFB): HDACs as regulators of T cell-mediated immunity in health and disease (funded by the Austrian Science Fund; FWF) (W. Ellmeier is speaker and project leader of the SFB; N. Boucheron is project leader) <link press release> <www.meduniwien.ac.at/HIT>
++ 10/2018 - Daniela Hainberger received a L'Oreal Austria Fellowship - FOR WOMEN IN SCIENCE <pdf>
++ 07/2018 - New publication in Nature Reviews Immunology: Histone deacetylase function in CD4+ T cells <link>
++ 04/2018 - Newspaper artikel about the PhD project of Patricia Hamminger (in German) <pdf>
++ 12/2017 - Funding of the FWF doc.fund application "Molecular and Cellular Control of Tissue Homeostasis in Health and Disease - TissueHome" (the Ellmeier lab is part of the initiative) <link>
+++ 11/2017 - Poster prize for Liisa Andersen - 2017 Annual meeting of the Austrian Society of Allergology and Immunology <link>
++ 11/2017 - New publication of our lab on the role of NCOR1 during T cell development <link>
++ 10/2017 - Two FWF-funded PhD positions available <link>
++ 10/2017 - Nicole Boucheron received a stand alone FWF project
++ 10/2017 - Special issue of FEBS letters on "Immunity & Metabolism" published (edited by Laszlo Nagy and Wilfried Ellmeier) <link>
++ 09/2017 - New publication of our lab about the role of HDAC1 in EAE in the Journal of Autoimmunity <link>
++ 08/2017 - Patricia Hamminger received a DOC fellowship of the Austrian Academy of Sciences <link>

Press releases / Presseaussendungen (in German)

Our research is funded by public money (e.g. Austrian Science Fund, WWTF, HORIZON 2020), therefore we have a strong committment to communicate our results also to the interested public.

• HEUREKA Artikel über PhD Projekt von Patricia Hamminger <pdf>
• WissensDurst Vortrag (pint of science) von Wilfried Ellmeier am 23.4.2018 <pdf>
• Möglicher therapeutischer Ansatz für Multiple Sklerose entdeckt <pdf>
• Possible approach discovered for the treatment of multiple sclerosis <link>
• T-Helfer-Zellen können ihren Charakter ändern <pdf>
• Chromatin-modifizierendes Enzym beeinflusst Asthma <pdf>
• Neue Horizonte <pdf>
• Wesentlicher Faktor für T-Zellbildung entdeckt <pdf>
• Immunsystem - Toleranz <pdf>
• Forschung - Identitätssucher in der Biochemie <pdf>


Top of the page

Social media

copyright 2000-2021 E L L M E I E R - L A B. All rights reserved.